Key points from article :
GlaxoSmithKline employs online technology and a data algorithm developed by F1’s elite McLaren Applied Technologies team.
Potential lies in its ability to fine tune research and clinical trials.
Helped by continued falls in data storage costs and improving computing power.
Handling the personal details of millions of people creates huge data quality, privacy and security problems.
Data gathered 10 years ago by a brain scan is infinitely less detailed than what you would get today